The consumer genomics firm Helix will use an FDA-cleared device from OraSure's subsidiary DNA Genotek for collecting DNA samples from customers.
The new partners plan to develop apps for Helix's DNA sequencing platform related to ancestry, reproductive health, and food and drink.
"The idea is to open up a completely new market for bringing genetics into the lower-risk general population," Invitae CEO Randy Scott told GenomeWeb.
The first apps will be for individuals at low risk for inherited forms of cancer and heart disease, and will require a doctor's permission.
Helix plans to launch its first consumer products this year and has a goal of bringing its platform through US Food and Drug Administration clearance.
MIT Technology Review names the top 10 breakthrough technologies of 2016.
In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.
The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.
A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.
Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.